Highline Therapeutics' Series A Round

Highline Therapeutics raised a round of funding on August 24, 2015. Investors include Versant Ventures.

Highline Therapeutics focuses on accessing discovery technologies from New York City and Northeast academics.…

Articles about Highline Therapeutics' Series A Round: